Voluntary transparency Immunostainers and ready-to-use antibodies including maintenance
University Medical Center Utrecht (UMC Utrecht) intends to purchase five BenchMark Ultra® systems to cover the growing immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) workload. The current four systems have reached end-of-life and can no longer meet the requirements for protocol freedom, dual chromogenic ISH, and the use of Ready-To-Use (RTU) antibodies. The tender also includes a maintenance contract, disposables, and RTU antibodies. Market research shows that no other systems with comparable functionality are available, meaning competition is technically lacking. The procedure is a negotiation without publication, focused on one care process and one contract. The focus lies on technical compatibility, process efficiency, and the continuity of the diagnostic workflow.
Supplies · Onderhandeling zonder bekendmaking · European procedure
01What is being requested
University Medical Center Utrecht (UMC Utrecht) intends to purchase five BenchMark Ultra® systems to cover the growing immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) workload. The current four systems have reached end-of-life and can no longer meet the requirements for protocol freedom, dual chromogenic ISH, and the use of Ready-To-Use (RTU) antibodies. The tender also includes a maintenance contract, disposables, and RTU antibodies. Market research shows that no other systems with comparable functionality are available, meaning competition is technically lacking. The procedure is a negotiation without publication, focused on one care process and one contract. The focus lies on technical compatibility, process efficiency, and the continuity of the diagnostic workflow.
The Pathology department has experienced production growth in the number of samples offered over the past few years. This growth also leads to an increase in the number of immunohistochemical stains. To accommodate this production growth and achieve process efficiency, the pathology department intends to proceed with the purchase of an additional fifth BenchMark Ultra® system and to replace the current four machines because they are end-of-life. The contract consists in total of 5 BenchMark Ultra® systems, a maintenance contract, disposables, and Ready-To-Use (RTU) antibodies. It concerns one
02Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
03Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
04Likely competitors
05Legal themes that may be relevant here
06Frequently asked questions
What is the specific scope of the contract for the Pathology department?
Why was this specific equipment chosen?
Which technical requirements are important for the care process?
Why is there a lack of competition?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 300K
€ 515K
€ 1,7 mln
Gegunde waarden in CPV 38 · leveringen n=331